Title:
CRYSTALLINE SALTS OF CORYDALMINE
Document Type and Number:
WIPO Patent Application WO/2020/108330
Kind Code:
A1
Abstract:
The present disclosure relates to crystalline salt forms of the following Compound (1), also known as l-corydalmine or l-CDL, and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in methods for the treatment of chronic pain, anxiety, insomnia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome, et al.
More Like This:
Inventors:
YANG ZHENG (CN)
LI ZHENG JANE (CN)
YANG HONGJU (CN)
SHI ZHICONG (CN)
LI ZHENG JANE (CN)
YANG HONGJU (CN)
SHI ZHICONG (CN)
Application Number:
PCT/CN2019/118903
Publication Date:
June 04, 2020
Filing Date:
November 15, 2019
Export Citation:
Assignee:
YANG ZHENG (CN)
International Classes:
C07D455/03; A61K31/4375; A61K31/4745; A61P1/16; A61P3/04; A61P3/10; A61P25/00; A61P25/22; A61P29/00
Domestic Patent References:
WO2009002873A1 | 2008-12-31 |
Foreign References:
CN107260738A | 2017-10-20 | |||
CN106176740A | 2016-12-07 | |||
CN103214477A | 2013-07-24 |
Other References:
See also references of EP 3887367A4
Attorney, Agent or Firm:
KING & WOOD MALLESONS (CN)
Download PDF: